• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of new cytokine IL-38 in COPD

Research Project

Project/Area Number 26860619
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Respiratory organ internal medicine
Research InstitutionKurume University

Principal Investigator

Kinoshita Takashi  久留米大学, 医学部, 助教 (90454917)

Project Period (FY) 2014-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
KeywordsCOPD / サイトカイン / 炎症 / IL-38 / 豚膵臓エラスターゼ / 急性肺障害 / 薬剤性肺炎
Outline of Final Research Achievements

We generated anti-human monoclonal anti-human IL-38 monoclonal antibodies in order to perform immunohistochemical staining and an enzyme-linked immunosorbent assay. IL-1 beta and IL-6 in an autoantibody-induced rheumatoid arthritis mouse model of C57BL/6 IL-38(-/-) mice were higher than WT mice. IL-38 may acts as an inhibitor of inflammation. Therefore, to investigate the biological role of IL-38 for lung, bone, and weight, we observed both WT and IL-38 KO mice. We have no significant differences both of them. Next, IL-38 KO mice were used in elastase-induced emphysema model. Eosinophil and Lymphocyte after elastase treatment in bronchoalveolar lavage fluid of IL-38 KO mice were suppressed compared to WT mice. IL-38 may have a role in inflammation of elastase-induced emphysema model.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2017-05-10  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi